Literature DB >> 2857752

Neutralizing antibodies to pertussis toxin in whooping cough.

M Granström, G Granström, P Gillenius, P Askelöf.   

Abstract

The development and duration of neutralizing antibodies (antitoxin) to pertussis toxin were studied in 38 patients with culture-verified infections due to Bordetella pertussis and one patient with infection due to Bordetella parapertussis. An in vitro neutralization test in microplate culture of Chinese hamster ovary cells was used. An antitoxin response was recorded in 36 patients, the exceptions being two patients treated early with erythromycin (one of whom developed clinical pertussis two years later) and the patient with infection due to B. parapertussis. A long-term follow-up for several months to several years after disease showed maintenance of high antitoxin levels. These results are in accordance with the hypothesis that antibodies to pertussis toxin mediate long-term immunity to whooping cough.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2857752     DOI: 10.1093/infdis/151.4.646

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.

Authors:  S M Loosmore; G R Zealey; H A Boux; S A Cockle; K Radika; R E Fahim; G J Zobrist; R K Yacoob; P C Chong; F L Yao
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Elimination of interfering activity in serum samples in the Chinese hamster ovary pertussis serology assay.

Authors:  Erik Østergaard; Charlotte Sørensen; Lene Nielsen; Gitte Stawski
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

3.  Evaluation of serologic assays for diagnosis of whooping cough.

Authors:  G Granström; B Wretlind; C R Salenstedt; M Granström
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

4.  Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in Senegalese infants.

Authors:  F Simondon; A Yam; J Y Gagnepain; S Wassilak; B Danve; M Cadoz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

Review 5.  Pertussis: the disease and new diagnostic methods.

Authors:  R L Friedman
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

6.  Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization.

Authors:  Jamie N Sutherland; Christine Chang; Sandra M Yoder; Michael T Rock; Jennifer A Maynard
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

7.  Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.

Authors:  L Nencioni; M Pizza; M Bugnoli; T De Magistris; A Di Tommaso; F Giovannoni; R Manetti; I Marsili; G Matteucci; D Nucci
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

8.  Simple, speedy, sensitive, and specific serodiagnosis of pertussis by using a particle agglutination test.

Authors:  T Aoyama; T Kato; Y Takeuchi; K Kato; K Morokuma; T Hirai
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

9.  New, practical approach to detecting antibody to pertussis toxin for public health and clinical laboratories.

Authors:  K H Wong; S K Skelton
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

10.  Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay.

Authors:  G Zackrisson; I Krantz; T Lagergård; P Larsson; R Sekura; N Sigurs; J Taranger; B Trollfors
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.